Eurofins Scientific SE Share Price Deutsche Boerse AG
Equities
ESF
FR0000038259
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
53.62 EUR | -1.07% |
|
-4.59% | -9.73% |
10:59am | Eurofins: investigation launched into UK takeover of Cellmark | CF |
09:13am | UK Competition Watchdog Begins Probe of Eurofins' Purchase of Technical Testing, Analysis Business | MT |
Sales 2024 * | 7.06B 7.71B 594B | Sales 2025 * | 7.61B 8.32B 641B | Capitalization | 9.31B 10.18B 784B |
---|---|---|---|---|---|
Net income 2024 * | 415M 454M 34.94B | Net income 2025 * | 525M 574M 44.2B | EV / Sales 2024 * | 1.76 x |
Net Debt 2024 * | 3.07B 3.36B 259B | Net Debt 2025 * | 3.04B 3.32B 256B | EV / Sales 2025 * | 1.62 x |
P/E ratio 2024 * |
22.3
x | P/E ratio 2025 * |
17.8
x | Employees | - |
Yield 2024 * |
1.24% | Yield 2025 * |
1.65% | Free-Float | 66.78% |
Latest transcript on Eurofins Scientific SE
1 day | -1.07% |
Managers | Title | Age | Since |
---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 61 | 31/12/86 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 31/12/14 |
Christian Wurst
COO | Chief Operating Officer | - | 30/09/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 61 | 31/12/86 |
Yves-Loïc Martin
BRD | Director/Board Member | 58 | 31/12/91 |
Valérie Hanote
BRD | Director/Board Member | 58 | 31/12/90 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.32% | 84.59B | |
-21.99% | 77.33B | |
+0.92% | 27.12B | |
-5.06% | 18.19B | |
+7.91% | 18.49B | |
+7.69% | 16.49B | |
+76.20% | 13.55B | |
+76.56% | 13.03B | |
-27.72% | 12.43B |
- Stock Market
- Equities
- ERF Stock
- ESF Stock